MedTrace Logo

Evaluation of Auto-EPAP for Management of Upper Airway Obstruction During Non-Invasive Ventilation

NCT06560411 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2026-01-28

No results posted yet for this study

Summary

To evaluate the safety and effectiveness of the Automatic Expiratory Positive Airway Pressure (Auto-EPAP) feature versus manual expiratory positive airway pressure (EPAP) in the Vivo 45 LS Ventilator.

Conditions

  • Obstructive Sleep Apnea
  • Obesity Hypoventilation Syndrome (OHS)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Neuromuscular Diseases (NMD)

Interventions

DEVICE

Non-Invasive Ventilation

Provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation

Sponsors & Collaborators

  • Veranex, Inc.

    collaborator UNKNOWN

  • Breas Medical, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-03
Primary Completion
2025-08-07
Completion
2025-08-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06560411 on ClinicalTrials.gov